Related Experiment Video
Updated: Sep 6, 2025
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.8K
Treatment of Depression with Botulinum Toxin
Marc Axel Wollmer1, Michelle Magid2, Tillmann H C Kruger3,4
1Asklepios Clinic North-Ochsenzoll, Asklepios Campus Hamburg, Medical Faculty, Semmelweis University, 22419 Hamburg, Germany.
Toxins
|June 23, 2022
Summary
Botulinum toxin (BoNT) injections in the face show promise for treating depression with few side effects. This review covers evidence, mechanisms, and practical use of BoNT for mental health disorders.
Area of Science:
- Neurology
- Psychiatry
- Pharmacology
Background:
- Depression is a prevalent mental health disorder with significant unmet treatment needs.
- Current antidepressant therapies have limitations, including side effects and variable efficacy.
- Botulinum toxin (BoNT) injections are being explored as a novel therapeutic approach.
Purpose of the Study:
- To review existing clinical and experimental evidence for the antidepressant effects of BoNT.
- To explore the theoretical background and potential mechanisms of action for BoNT in depression.
- To provide guidance on the safe and effective application of BoNT for depression treatment.
Main Methods:
- Review of clinical trials and experimental studies on BoNT for depression.
- Analysis of proposed neurobiological and psychological mechanisms.
- Compilation of practical guidelines for administration.
Main Results:
- Evidence suggests BoNT injections may have antidepressant effects.
- Potential mechanisms include altered facial feedback, reduced negative rumination, and anti-inflammatory effects.
- BoNT offers a long-lasting effect with a favorable side effect profile.
Conclusions:
- BoNT represents a novel and promising treatment for depression.
- Further clinical development is ongoing to establish its role in managing mental disorders.
- BoNT may offer a valuable alternative or adjunct therapy for depression.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
750
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
750
01:30Electroconvulsive Therapy
139
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
139
01:23Antidepressant Drugs: MAOIs and Other Agents
326
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
326
01:20Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
01:05Long-term Depression
31.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.4K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
608
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
608